271 related articles for article (PubMed ID: 2142949)
1. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure.
Kurnik BR; Weisberg LS; Cuttler IM; Kurnik PB
J Lab Clin Med; 1990 Jul; 116(1):27-36. PubMed ID: 2142949
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.
Kurnik BR; Allgren RL; Genter FC; Solomon RJ; Bates ER; Weisberg LS
Am J Kidney Dis; 1998 Apr; 31(4):674-80. PubMed ID: 9531185
[TBL] [Abstract][Full Text] [Related]
3. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide.
Morikawa S; Sone T; Tsuboi H; Mukawa H; Morishima I; Uesugi M; Morita Y; Numaguchi Y; Okumura K; Murohara T
J Am Coll Cardiol; 2009 Mar; 53(12):1040-6. PubMed ID: 19298916
[TBL] [Abstract][Full Text] [Related]
4. Measurement of changes in glomerular filtration rate induced by atrial natriuretic peptide in the rat kidney.
Caron N; Kramp R
Exp Physiol; 1999 Jul; 84(4):689-96. PubMed ID: 10481226
[TBL] [Abstract][Full Text] [Related]
5. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide infusion improves ischemic renal failure after suprarenal abdominal aortic cross-clamping in dogs.
Mitaka C; Hirata Y; Habuka K; Narumi Y; Yokoyama K; Makita K; Imai T
Crit Care Med; 2003 Aug; 31(8):2205-10. PubMed ID: 12973181
[TBL] [Abstract][Full Text] [Related]
7. Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency.
Hans SS; Hans BA; Dhillon R; Dmuchowski C; Glover J
Am Surg; 1998 May; 64(5):432-6. PubMed ID: 9585778
[TBL] [Abstract][Full Text] [Related]
8. Radiocontrast-induced nephropathy: current status and future prospects.
Margulies K; Schirger J; Burnett J
Int Angiol; 1992; 11(1):20-5. PubMed ID: 1387889
[TBL] [Abstract][Full Text] [Related]
9. Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
Burnier M; Mooser V; Wauters JP; Marder HK; De Vane P; Nussberger J; Waeber B; Brunner HR
J Cardiovasc Pharmacol; 1989 May; 13(5):682-90. PubMed ID: 2472515
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma levels of atrial natriuretic peptide in patients with chronic renal failure: effect of noradrenaline infusion.
Jespersen B; Pedersen EB
Nephrol Dial Transplant; 1988; 3(6):762-7. PubMed ID: 2976128
[TBL] [Abstract][Full Text] [Related]
11. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
Fujisaki K; Kubo M; Masuda K; Tokumoto M; Hirakawa M; Ikeda H; Matsui R; Matsuo D; Fukuda K; Kanai H; Hirakata H; Iida M
Clin Exp Nephrol; 2003 Dec; 7(4):279-83. PubMed ID: 14712357
[TBL] [Abstract][Full Text] [Related]
12. Effect of 1-28 alpha-h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation.
Gianello P; Carlier M; Jamart J; Hulhoven R; Bernheim J; Bernard A; Ketelslegers JM; Squifflet JP
Clin Transplant; 1995 Dec; 9(6):481-9. PubMed ID: 8645892
[TBL] [Abstract][Full Text] [Related]
13. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
[TBL] [Abstract][Full Text] [Related]
14. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
15. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus.
Weisberg LS; Kurnik PB; Kurnik BR
Kidney Int; 1994 Jan; 45(1):259-65. PubMed ID: 8127017
[TBL] [Abstract][Full Text] [Related]
16. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
[TBL] [Abstract][Full Text] [Related]
17. Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure.
Swärd K; Valson F; Ricksten SE
Acta Anaesthesiol Scand; 2001 May; 45(5):536-42. PubMed ID: 11309000
[TBL] [Abstract][Full Text] [Related]
18. Interaction of atrial natriuretic peptide and amiloride on renal hemodynamics through renal kallikrein and kinins in anesthetized rabbits.
Seino M; Abe K; Nushiro N; Omata K; Yoshinaga K
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S39-42. PubMed ID: 2473347
[TBL] [Abstract][Full Text] [Related]
19. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
[TBL] [Abstract][Full Text] [Related]
20. [The effects of atrial natriuretic peptide on left ventricular function in subjects with heart failure].
Indolfi C; Piscione F; Volpe M; Lembo G; De Campora P; Russolillo E; Ambrosini V; Condorelli M; Chiariello M
Cardiologia; 1991 May; 36(5):351-6. PubMed ID: 1836751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
